Mario Gabelli Sanofi Transaction History

Gamco Investors, Inc. Et Al

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 05, 2021	SELL	$45.3 - $51.62 $495,808 - $564,980	-10,945 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$38.02 - $51.66 $26,614 - $36,162	-700 Reduced 6.01%	10,945 $479,000
Q4 2019 Feb 14, 2020	SELL	$44.25 - $50.86 $53,100 - $61,032	-1,200 Reduced 9.34%	11,645 $585,000
Q3 2019 Nov 01, 2019	BUY	$40.34 - $46.64 $25,212 - $29,150	625 Added 5.11%	12,845 $595,000
Q2 2019 Aug 02, 2019	BUY	$40.43 - $44.3 $494,054 - $541,346	12,220 New	12,220 $529,000

820

274M

1.9M

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $121B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

Get notified when there are updates to the investment portfolio of Gamco Investors, Inc. Et Al, based on Form 13F filings with the SEC.

Stay updated on Gamco Investors, Inc. Et Al and Mario Gabelli with notifications on news.